These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Protocols to Manufacture an Oncolytic Measles Virus-Sensitive Immunocompetent Mouse Model of Medulloblastoma. Lal S; Raffel C Methods Mol Biol; 2022; 2423():165-177. PubMed ID: 34978698 [TBL] [Abstract][Full Text] [Related]
26. Frequent Homozygous Deletions of Type I Interferon Genes in Pleural Mesothelioma Confer Sensitivity to Oncolytic Measles Virus. Delaunay T; Achard C; Boisgerault N; Grard M; Petithomme T; Chatelain C; Dutoit S; Blanquart C; Royer PJ; Minvielle S; Quetel L; Meiller C; Jean D; Fradin D; Bennouna J; Magnan A; Cellerin L; Tangy F; Grégoire M; Fonteneau JF J Thorac Oncol; 2020 May; 15(5):827-842. PubMed ID: 31945495 [TBL] [Abstract][Full Text] [Related]
27. NK Cell Effector Functions and Bystander Tumor Cell Killing in Immunovirotherapy. Floerchinger A; Engeland CE Methods Mol Biol; 2022; 2521():233-248. PubMed ID: 35733001 [TBL] [Abstract][Full Text] [Related]
28. Dual therapy of ovarian cancer using measles viruses expressing carcinoembryonic antigen and sodium iodide symporter. Hasegawa K; Pham L; O'Connor MK; Federspiel MJ; Russell SJ; Peng KW Clin Cancer Res; 2006 Mar; 12(6):1868-75. PubMed ID: 16551872 [TBL] [Abstract][Full Text] [Related]
29. Generation of recombinant measles virus containing the wild-type P gene to improve its oncolytic efficiency. Alizadeh R; Ghanei M; Arashkia A; Dorostkar R; Azadmanesh K Microb Pathog; 2019 Oct; 135():103631. PubMed ID: 31381964 [No Abstract] [Full Text] [Related]
30. Oncolytic measles virus as a novel therapy for malignant peripheral nerve sheath tumors. Deyle DR; Escobar DZ; Peng KW; Babovic-Vuksanovic D Gene; 2015 Jul; 565(1):140-5. PubMed ID: 25843626 [TBL] [Abstract][Full Text] [Related]
31. Photocontrollable mononegaviruses. Tahara M; Takishima Y; Miyamoto S; Nakatsu Y; Someya K; Sato M; Tani K; Takeda M Proc Natl Acad Sci U S A; 2019 Jun; 116(24):11587-11589. PubMed ID: 31138700 [TBL] [Abstract][Full Text] [Related]
32. Expression of RNA interference triggers from an oncolytic herpes simplex virus results in specific silencing in tumour cells in vitro and tumours in vivo. Anesti AM; Simpson GR; Price T; Pandha HS; Coffin RS BMC Cancer; 2010 Sep; 10():486. PubMed ID: 20836854 [TBL] [Abstract][Full Text] [Related]
33. Chemovirotherapeutic Treatment Using Camptothecin Enhances Oncolytic Measles Virus-Mediated Killing of Breast Cancer Cells. Tai CJ; Liu CH; Pan YC; Wong SH; Tai CJ; Richardson CD; Lin LT Sci Rep; 2019 May; 9(1):6767. PubMed ID: 31043633 [TBL] [Abstract][Full Text] [Related]
34. Expression of Oncolytic Adenovirus-Encoded RNAi Molecules Is Most Effective in a pri-miRNA Precursor Format. Brachtlova T; van Ginkel JW; Luinenburg MJ; de Menezes RX; Koppers-Lalic D; Pegtel DM; Dong W; de Gruijl TD; van Beusechem VW Mol Ther Oncolytics; 2020 Dec; 19():332-343. PubMed ID: 33335978 [TBL] [Abstract][Full Text] [Related]